Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)-
- CAS No.
- 112245-04-2
- Chemical Name:
- Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)-
- Synonyms
- [112245-04-2;(R)-2-(2-(tert-Butoxy)-2-oxoethyl)-4-methylpentanoic acid;(2R)-2-[2-(tert-butoxy)-2-oxoethyl]-4-methylpentanoic acid;(2R)-2-[(tert-Butoxycarbonyl)methyl]-4-(methyl)pentanoic acid;Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester;(2R)-4-methyl-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]pentanoic acid;Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)-
- CBNumber:
- CB22729253
- Molecular Formula:
- C12H22O4
- Molecular Weight:
- 230.3
- MDL Number:
- MFCD24396363
- MOL File:
- 112245-04-2.mol
- MSDS File:
- SDS
Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)- price More Price(13)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Matrix Scientific | 308924 | (R)-2-(2-(tert-Butoxy)-2-oxoethyl)-4-methylpentanoic acid | 112245-04-2 | 250.00mg | $78 | 2026-05-19 | Buy |
| Matrix Scientific | 308924 | (R)-2-(2-(tert-Butoxy)-2-oxoethyl)-4-methylpentanoic acid | 112245-04-2 | 1.00g | $176 | 2026-05-19 | Buy |
| Matrix Scientific | 308924 | (R)-2-(2-(tert-Butoxy)-2-oxoethyl)-4-methylpentanoic acid | 112245-04-2 | 5.00g | $522 | 2026-05-19 | Buy |
| aablocks | AA0095XX | (R)-2-(2-(Tert-Butoxy)-2-Oxoethyl)-4-Methylpentanoic Acid 95% | 112245-04-2 | 250mg | $38 | 2026-05-28 | Buy |
| aablocks | AA0095XX | (R)-2-(2-(Tert-Butoxy)-2-Oxoethyl)-4-Methylpentanoic Acid 95% | 112245-04-2 | 1g | $91 | 2026-05-28 | Buy |
Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)- Chemical Properties,Uses,Production
Synthesis
144287-83-2
112245-04-2
GENERAL PROCEDURE: (R)-2-(2-(tert-butoxy)-2-oxoethyl)-4-methylpentanoic acid was prepared according to Scheme 2 (steps a-d). Step a: To a solution of 3-cyclopentylpropionic acid (46.6 g, 0.33 mol) in freshly distilled anhydrous THF (0.9 M) was added triethylamine (52 mL, 0.38 mol), the mixture was cooled to -78 °C and pivaloyl chloride (41 mL, 0.33 mol) was added dropwise. After stirring at -78 °C for 15 minutes, the mixture was warmed to room temperature and stirring was continued for 1 hour (a white suspension was formed). Step b: To a solution of (S)-4-benzyloxazolidin-2-one (59.2 mg, 0.33 mol) in freshly distilled THF was added nBuLi (2.5 M solution in THF, 134 mL, 0.33 mol) and the mixture was stirred for 20 min at -78 °C. Subsequently, the mixture was added to the above pre-cooled (-78 °C) pivalic anhydride. The reaction mixture was stirred at -78 °C for 30 min and then the cooling bath was removed to bring the reaction to room temperature. Saturated aqueous NH4Cl solution (500 mL) was added and the aqueous phase was extracted with EtOAc (2 x 200 mL). The organic extracts were combined, dried with MgSO4, filtered and concentrated in vacuum. Rapid chromatographic purification of the crude product using a petroleum ether solution of 20% EtOAc afforded 91 g (91%) of (S)-4-benzyl-3-(3-cyclopentylpropionyl)oxazolidin-2-one (34) as a white solid. Step c: NaHMDS (1 M, THF, 410 mL, 0.41 mol) was added dropwise to a stirred solution of 34 (95 g, 0.315 mol) in THF (0.08 M) at -78 °C over 1 h, followed by tert-butyl bromoacetate (70 mL, 0.41 mol) dropwise over 30 min. The cooling bath was removed and the reaction mixture was allowed to warm to room temperature and stirred overnight. Subsequently, the mixture was cooled with an ice bath, saturated aqueous NH4Cl solution (300 mL) and water (100 mL) were added slowly and the aqueous phase was extracted with EtOAc (200 mL). The organic extracts were combined, dried with Na2SO4, filtered and evaporated to dryness. The crude product was purified by fast chromatography using a petroleum ether gradient of 5-30% EtOAc to afford 73 g (56%) of tert-butyl (R)-4-((S)-4-benzyl-2-oxoxoxazolidin-3-yl)-3-(cyclopentylmethyl)-4-oxobutanoate (38) as a white solid. Step d: To a stirred solution of 38 (73 g, 0.18 mol) in 750 mL THF/water (4:1, v/v) was added H2O2 (35% aqueous solution, 68 mL, 0.7 mol) dropwise over 15 min at 0 °C. After continued stirring for 10 min, 1 M aq LiOH (300 mL, 0.35 mol) was added dropwise over 15 min, followed by warming the mixture to room temperature and stirring for 16 h until the completion of the reaction was confirmed by LCMS. The reaction mixture was cooled with an ice bath and an aqueous (1 L) solution of sodium bisulfite (225 g, 1.8 mol) was added dropwise over 1 h (note: this process is slightly exothermic). Most of the THF was removed in vacuo, and the resulting aqueous layer (pH ~12) was washed with Et2O (3 × 500 mL), cooled (ice bath) and acidified to pH 1 with 6 M HCl. The extract was extracted with EtOAc (5 × 500 mL), the extracts were combined, dried over MgSO4, filtered and concentrated to dryness in vacuo to give (R)-2-(2-(tert-butoxy)-2-oxoethyl)-4 -methylpentanoic acid (42) (30 g, 65%) as a light yellow oil.
References
[1] Journal of the American Chemical Society, 2013, vol. 135, # 24, p. 9139 - 9148
[2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 18, p. 5169 - 5180
[3] Journal of Medicinal Chemistry, 1998, vol. 41, # 2, p. 199 - 223
[4] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 10, p. 1783 - 1786
[5] Patent: US2004/82568, 2004, A1. Location in patent: Page/Page column 29-30
Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)- Preparation Products And Raw materials
Raw materials
Preparation Products
Butanedioic acid, 2-(2-Methylpropyl)-, 4-(1,1-diMethylethyl) ester, (2R)- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| SINO High Goal Chemical Technology Co., Ltd. | 021-57646680 18306277365 | sunkai@chembiobanksh.com | China | 2039 | 55 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 18149758185 | sales-cpd@caerulumpharma.com | China | 3493 | 58 |
| DKMbiochem.Co. Ltd | 15901859516 | sales@DKMbiochem.com | China | 361 | 58 |
| Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66028182 17714375163 | yftan@aikonchem.com | China | 16674 | 50 |
| Shanghai Synchem Pharma Co., ltd | 21-619849051-1 18521059765 | synchempharma@aliyun.com | China | 4988 | 55 |
| ChengDu TongChuangYuan Pharmaceutical Co.Ltd | 028-83379370 13880556291 | tcy@tcypharm.com | China | 8696 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131885 | 58 |
| Cck Pharmchem Co.,Ltd | 0512-68131995 13862051930 | China | 360 | 55 | |
| Nanjing KaiMubo Pharmaceutical Co., Ltd. | 025-66162170 | China | 7180 | 55 | |
| Changzhou Kechem Bio-Scientific Co., LTD. | 0519-68985668 13685222090 | sales@kechem.cn | China | 26012 | 58 |
